Concepedia
Statistics
Publications
6
Citations
2.2K
H-Index
Active since
2010
Affiliations
Virginia Commonwealth University(Current)
Pinnacle Clinical Research
Indiana University School of Medicine
Hospital Universitario La Paz
Newcastle University
Muhammad Y. Sheikh is an author at Virginia Commonwealth University specializing in medicine, liver disease, and hepatology.
Publications per year
2010–2020
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text
Medicine, Internal Medicine, Pharmacology +8
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations
Medicine, Internal Medicine, Pharmacotherapy +12
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Stephen A. Harrison, Zachary Goodman, Abdul Jabbar et al. · Journal of Hepatology · 2019 · 251 citations
Medicine, Internal Medicine, Pathology +10
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of GS-9450 in Subjects With Nonalcoholic Steatohepatitis
Vlad Ratziu, Muhammad Y. Sheikh, Arun J. Sanyal et al. · Hepatology · 2011 · 163 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis
Ju Dong Yang, Manal F. Abdelmalek, Cynthia D. Guy et al. · Clinical Gastroenterology and Hepatology · 2016 · 92 citations · Full text
Medicine, Endocrinology, Pathology +16
1–5 of 6